Additionally, a case presentation reported data from a woman with HR+, HER2– breast cancer and brain metastases causing right-sided blindness was published [30], in which ribociclib plus anastrozole treatment resulted in a fast and durable complete response to ribociclib treatment lasting 9 months. This evidence concerns the gene ERBB2 and breast cancer.